SCRS is committed to ensuring the sites’ voice is heard and knowledge related to the management of a research site is understood.

Periodically, SCRS conducts surveys to arrive at answers to these critical goals. We invite SCRS members and non-members to participate in any of our surveys.

Available surveys are listed below. If no surveys are listed, please check back regularly.

All contributors will have the opportunity to provide their email address to receive an executive summary of the survey results. SCRS respects your privacy and at no time shares your contact information with anyone. All results remain anonymous.

Please invite other site personnel to participate by forwarding the below survey links.

Thank you in advance for contributing to the dialogue, and remember: “… the community, the citizens acting together, can do a number of things better than if they were left to individual action.”

–Theodore Roosevelt

2020 Site Landscape Survey

The Site Landscape Survey is designed to help us understand your experience in the following key areas: 

  • Staffing  
  • Budgeting Terms  
  • Site Finances  
  • Decentralized Trials 
You will have the option to skip any sections that do not pertain to your work and expertise.
It should take you no longer than 5 minutes to complete.
Thank you for contributing your voice to this important conversation!

Sites Now Survey

Sites provide a unique intersection of research operations and patient care. Like many businesses, sites are evolving through the impact that COVID-19 continues to have in 2020 and beyond.

SCRS will host the first of an ongoing program called Sites NOW later this month. The first topic “Why Sites Matter in the new 2020” will explore opportunities for awareness and impact that sites can have on the clinical research enterprise now and in the future.

Please help us inform our Sites NOW program by answering 2 questions on the importance of sites and what we need to thrive.

How effectively are sponsors working with sites during COVID-19?

The global COVID-19 pandemic has substantially impacted the global healthcare delivery system, including the conduct of clinical trials in many geographies. A major pharmaceutical company would like to gather insights from you regarding your and your patient’s experiences and the benefit of trial mitigations that were put in place to ensure continuation of patient care and trial participation. We would like to learn from your experiences – what worked well, what didn’t, and how to incorporate more flexibility into protocols and operational execution.

Please let us know how effectively sponsors are working with you during the COVID-19 pandemic by taking a brief survey.